The Williams Companies, Inc. · WMB · FY2026 Q3 · Calendar Q4 2026
Williams posts record Q3 EBITDA; holds 2026 guidance
Williams’ record Q3 adjusted EBITDA and progress integrating Momentum Midstream support its growth narrative, while maintained guidance and permitting, leverage and project-execution risks temper the outlook. The call analysis says management sees a long-term growth path above 11% CAGR through 2030, with a 16% high-end scenario discussed; those remain forward targets, not achieved results.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about WMB FY2026 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with Q2, the Momentum Midstream acquisition has closed and management described early synergy capture; Socrates Phase II is nearing commissioning ahead of schedule and within budget. Q3 adjusted EBITDA exceeded $2 billion, placing Williams in the upper half of its 2026 guidance range. Management maintained, rather than raised, its 2026 guidance, following the prior quarter’s increase.
Guidance delta
Management maintained full-year 2026 EBITDA guidance and capex guidance. Q3 results put the company in the upper half of its EBITDA range; the supplied analysis does not indicate a new numerical guidance range or a change to it this quarter.
Key takeaways
- Record Q3 adjusted EBITDA above $2 billion places Williams in the upper half of its 2026 guidance range.
- Management said the Momentum acquisition closed ahead of schedule, with early synergies, and Socrates Phase II is expected online ahead of schedule and within budget.
- The call pointed to pipeline and storage expansions, power projects, and long-term contracted demand as growth drivers; management maintained its 2026 outlook.
Management priorities
- Advance Transco, SESI Phase II and Garden Connector expansions, including a possible SESI Phase III and a Garden Connector upsize.
- Commission Socrates Phase II and announce one or two additional power projects by year-end, as described on the call.
- Pursue natural-gas storage expansions and retain flexibility for M&A or joint-venture financing.
Follow WMB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| CIBC | Outperform | Outperform | Maintain | Oct 22, 2026 |
| Jefferies | Buy | Buy | Maintain | Oct 14, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 18, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 12, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 10, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 5, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 8, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 1, 2026 |
| UBS | Buy | Buy | Maintain | May 12, 2026 |
| Citigroup | Buy | Buy | Maintain | May 8, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 7, 2026 |
| Stifel | Buy | Buy | Maintain | May 6, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 20, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 5, 2025 |
| Argus Research | Buy | Buy | Maintain | Aug 14, 2025 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jun 13, 2025 |
| Mizuho | Outperform | Outperform | Maintain | Nov 4, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Jul 30, 2024 |
| Raymond James | Outperform | Strong Buy | Downgrade | Apr 21, 2023 |
| Bernstein | Market Perform | Outperform | Downgrade | Feb 27, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 16, 2022 |
| B of A Securities | Buy | Buy | Maintain | Jan 18, 2022 |
| TD Securities | Buy | Buy | Maintain | Feb 24, 2021 |
| Bank of America | Buy | Buy | Maintain | Nov 2, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Evercore Partners | Buy | Buy | Maintain | Aug 2, 2016 |
| Evercore ISI Group | Buy | Buy | Maintain | Aug 2, 2016 |
| Tudor Pickering | Buy | Hold | Upgrade | Jul 21, 2016 |
| Deutsche Bank | Buy | Hold | Upgrade | Jun 17, 2014 |
| Maxim Group | Hold | Buy | Downgrade | Feb 12, 2014 |
| Scotia Howard Weil | Sector Perform | Sector Outperform | Downgrade | Jan 8, 2014 |
| ISI Group | Neutral | Buy | Downgrade | Oct 14, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| CIBC | Analyst unavailable | $82 | $70.04 | +12.3% | Oct 22, 2026 |
| Raymond James | Analyst unavailable | $85 | $73.97 | +16.4% | Oct 13, 2026 |
| Barclays | Theresa Chen | $82 | $67.97 | +12.3% | Oct 1, 2026 |
| Williams Trading | Analyst unavailable | $92 | $72.12 | +26.0% | Sep 22, 2026 |
| Scotiabank | Analyst unavailable | $85 | $73.54 | +16.4% | Sep 10, 2026 |
| Williams Trading | Analyst unavailable | $103 | $71.08 | +41.1% | Aug 26, 2026 |
| Morgan Stanley | Analyst unavailable | $103 | $75.54 | +41.1% | Aug 18, 2026 |
| Wells Fargo | Praneeth Satish | $90 | $71.51 | +23.3% | Aug 5, 2026 |
| CIBC | Analyst unavailable | $83 | $75.42 | +13.7% | Jul 14, 2026 |
| Morgan Stanley | Analyst unavailable | $99 | $74.46 | +35.6% | Jul 14, 2026 |
| Goldman Sachs | John MacKay | $82 | $74.46 | +12.3% | Jul 14, 2026 |
| Barclays | Theresa Chen | $75 | $75.08 | +2.7% | Jul 8, 2026 |
| Jefferies | Julien Dumoulin-Smith | $85 | $74.34 | +16.4% | Jul 1, 2026 |
| Argus Research | Analyst unavailable | $85 | $71.56 | +16.4% | May 29, 2026 |
| CIBC | Analyst unavailable | $85 | $76.89 | +16.4% | May 26, 2026 |
| Morgan Stanley | Analyst unavailable | $98 | $79.74 | +34.2% | May 20, 2026 |
| Scotiabank | Brandon Bingham | $86 | $74.18 | +17.8% | May 12, 2026 |
| UBS | Manav Gupta | $91 | $74.18 | +24.6% | May 12, 2026 |
| Jefferies | Analyst unavailable | $87 | $74.88 | +19.2% | May 6, 2026 |
| Mizuho Securities | Analyst unavailable | $82 | $75.16 | +12.3% | May 1, 2026 |
| Williams Trading | Analyst unavailable | $82 | $71.15 | +12.3% | Apr 20, 2026 |
| Jefferies | Julien Dumoulin-Smith | $83 | $72.27 | +13.7% | Apr 10, 2026 |
| Barclays | Theresa Chen | $73 | $72.17 | -0.0% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $81 | $72.28 | +11.0% | Feb 17, 2026 |
| UBS | Analyst unavailable | $89 | $72.28 | +21.9% | Feb 17, 2026 |
| Stifel Nicolaus | Analyst unavailable | $78 | $71.13 | +6.8% | Feb 12, 2026 |
| Williams Trading | Analyst unavailable | $84 | $71.13 | +15.1% | Feb 12, 2026 |
| BMO Capital | Analyst unavailable | $78 | $71.97 | +6.8% | Feb 12, 2026 |
| Wells Fargo | Analyst unavailable | $80 | $68.84 | +9.6% | Feb 11, 2026 |
| Jefferies | Analyst unavailable | $78 | $68.84 | +6.8% | Feb 11, 2026 |
| Jefferies | Analyst unavailable | $76 | $66.33 | +4.1% | Feb 2, 2026 |
| Mizuho Securities | Gabriel Moreen | $73 | $66.14 | -0.0% | Feb 2, 2026 |
| Scotiabank | Brandon Bingham | $66 | $61.68 | -9.6% | Jan 16, 2026 |
| Jefferies | Analyst unavailable | $71 | $61.02 | -2.7% | Jan 9, 2026 |
| Jefferies | Robert Mosca | $70 | $57.72 | -4.1% | Nov 5, 2025 |
| BMO Capital | Ameet Thakkar | $70 | $57.68 | -4.1% | Nov 5, 2025 |
| Barclays | Theresa Chen | $66 | $62.68 | -9.6% | Oct 14, 2025 |
| Williams Trading | Julien Dumoulin-Smith | $72 | $63.5 | -1.4% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $83 | $63.69 | +13.7% | Oct 2, 2025 |
| Barclays | Analyst unavailable | $65 | $63.18 | -11.0% | Sep 30, 2025 |
| UBS | Analyst unavailable | $78 | $63.97 | +6.8% | Sep 30, 2025 |
| Barclays | Analyst unavailable | $67 | $63.97 | -8.2% | Sep 30, 2025 |
| Williams Trading | Spiro Dounis | $65 | $57.88 | -11.0% | Aug 29, 2025 |
| Williams Trading | Robert Catellier | $64 | $57.34 | -12.3% | Aug 15, 2025 |
| Wells Fargo | Praneeth Satish | $70 | $57.89 | -4.1% | Aug 7, 2025 |
| Williams Trading | Stewart Glickman | $62 | $53.07 | -15.1% | Nov 8, 2024 |
| Mizuho Securities | Gabriel Moreen | $56 | $52.14 | -23.3% | Nov 4, 2024 |
| Williams Trading | Jean Ann Salisbury | $55 | $51.37 | -24.7% | Oct 17, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $55 | $51.37 | -24.7% | Oct 17, 2024 |
| Williams Trading | Robert Kad | $58 | $49.63 | -20.6% | Oct 4, 2024 |
| Barclays | Theresa Chen | $46 | $46.36 | -37.0% | Oct 2, 2024 |
| RBC Capital | Elvira Scotto | $47 | $44.67 | -35.6% | Aug 23, 2024 |
| Barclays | Theresa Chen | $42 | $44.13 | -42.5% | Aug 19, 2024 |
| CFRA | Stewart Glickman | $42 | $43 | -42.5% | Aug 7, 2024 |
| Mizuho Securities | Gabriel Moreen | $47 | $44.77 | -35.6% | Jul 22, 2024 |
| Truist Financial | Neal Dingmann | $42 | $41.02 | -42.5% | Jun 17, 2024 |
| RBC Capital | Elvira Scotto | $44 | $41.55 | -39.7% | Jun 13, 2024 |
| Williams Trading | Praneeth Satish | $46 | $40.98 | -37.0% | Jun 4, 2024 |
| Stifel Nicolaus | Selman Akyol | $43 | $39.32 | -41.1% | May 7, 2024 |
| Williams Trading | James Carreker | $40 | $39.27 | -45.2% | Apr 29, 2024 |
| Wolfe Research | Keith Stanley | $34 | $37.68 | -53.4% | Apr 18, 2024 |
| Goldman Sachs | John MacKay | $37 | $39.24 | -49.3% | Apr 10, 2024 |
| Morgan Stanley | Analyst unavailable | $41 | $32.63 | -43.8% | Jan 9, 2023 |
| Williams Trading | Michael Lapides | $30 | $33.29 | -58.9% | Sep 7, 2022 |
| Mizuho Securities | Analyst unavailable | $40 | $32.63 | -45.2% | Aug 3, 2022 |
| Raymond James | Analyst unavailable | $42 | $32.86 | -42.5% | Aug 3, 2022 |
| Wells Fargo | Praneeth Satish | $39 | $35.38 | -46.6% | May 22, 2022 |
| Argus Research | Bill Selesky | $40 | $34.62 | -45.2% | May 13, 2022 |
| RBC Capital | Analyst unavailable | $39 | $35.7 | -46.6% | May 4, 2022 |
| Williams Trading | Analyst unavailable | $37 | $33.8 | -49.3% | May 2, 2022 |
| Wells Fargo | Analyst unavailable | $38 | $34.34 | -47.9% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $40 | $33.9 | -45.2% | Apr 26, 2022 |
| Raymond James | Analyst unavailable | $40 | $35.74 | -45.2% | Apr 20, 2022 |
| Raymond James | Justin Jenkins | $36 | $29.73 | -50.7% | Feb 23, 2022 |
| Citigroup | Timm Schneider | $31 | $29.73 | -57.5% | Feb 23, 2022 |
| Barclays | Marc Solecitto | $34 | $29.73 | -53.4% | Feb 23, 2022 |
| UBS | Shneur Gershuni | $36 | $28.83 | -50.7% | Jan 26, 2022 |
| Bank of America Securities | Chase Mulvehill | $35 | $29.2 | -52.1% | Jan 18, 2022 |
| US Capital Advisors | Rebecca Followill | $30 | $27.19 | -58.9% | Nov 18, 2021 |
| Wolfe Research | Alex Kania | $29 | $28.2 | -60.3% | Oct 19, 2021 |
| Seaport Global | Sunil Sibal | $28 | $24.19 | -61.6% | Jul 28, 2021 |
| Argus Research | Bill Selesky | $30 | $25 | -58.9% | May 17, 2021 |
Track every rating change on WMB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Williams Companies, Inc., alongside its subsidiaries, operates as a prominent energy infrastructure entity, primarily conducting business throughout the United States. The company’s operations are organized into four key segments: Transmission & Gulf of Mexico, Northeast G&P, West, and Gas & NGL Marketing Services. The Transmission & Gulf of Mexico division manages crucial natural gas pipelines such as Transco and Northwest, in addition to natural gas gathering and processing, and crude oil production handling and transportation assets situated in the Gulf Coast. This segment also oversees various petrochemical and feedstock pipelines. Focusing on midstream activities, the Northeast G&P segment handles gathering, processing, and fractionation within the Marcellus Shale region, predominantly in Pennsylvania and New York, and the Utica Shale region of eastern Ohio.…
Historical context
All WMB earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.4% | +1.8% | Chevron posts strong Q3 as production, cash flow and AI value rise |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.2% | ExxonMobil Highlights Refining, LNG and Cash Returns in Q3 |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | +6.4% | +5.5% | Imperial Oil: downstream strength and low-carbon growth lead Q3 |
| CCJ Cameco Corporation | FY2026 Q3 · Calendar Q4 2026 | -101.4% | -7.9% | Cameco keeps nuclear-growth thesis intact as Key Lake outage weighs |
Latest beats and misses
Who reports nextBeat on EPS
- EQH-PAFY2026 Q3 · November 2, 2026+14.5% EPS— move
- TSEMFY2026 Q3 · November 2, 2026+7.5% EPS-6.7% move
- CLXFY2027 Q1 · November 2, 2026+44.9% EPS+2.2% move
- AAPLFY2026 Q4 · November 2, 2026+3.0% EPS-1.8% move
- PLTRFY2026 Q3 · November 2, 2026+8.3% EPS-3.1% move
- ETRFY2026 Q3 · November 2, 2026+14.5% EPS-0.2% move
Missed on EPS
- CRBGFY2026 Q3 · November 2, 2026-0.8% EPS+2.5% move
- VRTXFY2026 Q3 · November 2, 2026-1.2% EPS-1.0% move
- PEGFY2026 Q3 · November 2, 2026-3.4% EPS+0.1% move
- RYAAYFY2027 Q2 · November 2, 2026-0.3% EPS+2.9% move
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
Get the WMB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T16:08:25.576304+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T16:30:56.578657+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T16:30:56.575760+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.